The natural history and burden of illness of metachromatic leukodystrophy: a systematic literature review

The natural history and burden of illness of metachromatic leukodystrophy: a systematic literature review

Abstract Background Metachromatic leukodystrophy (MLD; OMIM 250100 and 249900) is a rare lysosomal storage disease caused by deficient arylsulfatase A activity, leading to accumulation of sulfatides in the nervous system. This systematic literature review aimed to explore the effect of MLD on the li...

Full description

Bibliographic Details
Main Authors:	Shun-Chiao Chang, Christian Stefan Eichinger, Polly Field
Format:	Article
Language:	English
Published:	BMC 2024-03-01
Series:	European Journal of Medical Research
Subjects:	Metachromatic leukodystrophy MLD Natural history Burden of illness Systematic literature review Lysosomal storage disease
Online Access:	https://doi.org/10.1186/s40001-024-01771-1

Similar Items

An international study of caregiver-reported burden and quality of life in metachromatic leukodystrophy
by: Caroline Sevin, et al.
Published: (2022-09-01)

Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers
by: Magdalena Harrington, et al.
Published: (2019-04-01)

The burden of disease in metachromatic leukodystrophy: results of a caregiver survey in the UK and Republic of Ireland
by: Sophie Thomas, et al.
Published: (2024-02-01)

A Case of Late Infantile Metachromatic Leukodystrophy Presenting with Gradually-onset Paraplegia
by: Seyed Ahmad Hosseini, et al.
Published: (2022-02-01)

A model of metformin mitochondrial metabolism in metachromatic leukodystrophy: first description of human Schwann cells transfected with CRISPR-Cas9
by: Nayibe Tatiana Sanchez-Álvarez, et al.
Published: (2022-07-01)

A systematic review on the birth prevalence of metachromatic leukodystrophy
by: Shun-Chiao Chang, et al.
Published: (2024-02-01)

Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)
by: Daphne H. Schoenmakers, et al.
Published: (2022-02-01)

Adult-Onset Metachromatic Leukodystrophy: Two Cases
by: Gaye Eryaşar, et al.
Published: (2011-12-01)

Adult-Onset Metachromatic Leukodystrophy: Two Cases
by: Gaye Eryaşar, et al.
Published: (2011-12-01)

Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective
by: Shanice Beerepoot, et al.
Published: (2019-11-01)

Insight into adult-onset metachromatic leukodystrophy with optic atrophy: A comprehensive case report
by: Shailendra Katwal, MD, et al.
Published: (2023-11-01)

Four novel ARSA gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutations
by: Dehghan Manshadi M, et al.
Published: (2017-06-01)

Optimization of Enzyme Essays to Enhance Reliability of Activity Measurements in Leukocyte Lysates for the Diagnosis of Metachromatic Leukodystrophy and Gangliosidoses
by: Sebastian Strobel, et al.
Published: (2020-11-01)

Metachromatic leukodystrophy
by: Prima Cheryl D′souza, et al.
Published: (2013-01-01)

Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy
by: F. Eichler, et al.
Published: (2022-10-01)

Allogenic hematopoietic stem cell transplantation in two siblings with adult metachromatic leukodystrophy and a systematic literature review
by: Cecilie Videbæk, et al.
Published: (2021-07-01)

Infantile Metachromatic Leukodystrophy: Case Report
by: Salsabeel Hamad, et al.
Published: (2023-11-01)

Metachromatic leukodystrophy: A case report
by: Gopen Kumar Kundu, et al.
Published: (2016-07-01)

Case report: A compound heterozygous mutations in ARSA associated with adult-onset metachromatic leukodystrophy
by: Bing-lei Wang, et al.
Published: (2022-10-01)

Phenotypic variation between siblings with Metachromatic Leukodystrophy
by: Saskia Elgün, et al.
Published: (2019-06-01)

The importance of early diagnosis and views on newborn screening in metachromatic leukodystrophy: results of a Caregiver Survey in the UK and Republic of Ireland
by: Georgina Morton, et al.
Published: (2022-11-01)

Three novel variants in the arylsulfatase A (ARSA) gene in patients with metachromatic leukodystrophy (MLD)
by: D. Hettiarachchi, et al.
Published: (2019-11-01)

Complete Correction of Brain and Spinal Cord Pathology in Metachromatic Leukodystrophy Mice
by: Emilie Audouard, et al.
Published: (2021-05-01)

Leukodystrophies /
by: Raymond, Gerald V., et al.
Published: (2011)

Dose-response evaluation of intravenous gene therapy in a symptomatic mouse model of metachromatic leukodystrophy
by: Emilie Audouard, et al.
Published: (2024-06-01)

Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire
by: Magdalena Harrington, et al.
Published: (2019-07-01)

Impact on physical, social, and family functioning of patients with metachromatic leukodystrophy and their family members in Japan: A qualitative study
by: Yuta Koto, et al.
Published: (2024-03-01)

An in silico approach to identify early damage biomarker candidates in metachromatic leukodystrophy
by: Jessica Gómez, et al.
Published: (2023-06-01)

Adult metachromatic leukodystrophy: case report
by: T. I. Prusova, et al.
Published: (2021-04-01)

A case of adult-onset metachromatic leukodystrophy beginning with behavioral symtoms
by: Hazan Tunalı, et al.
Published: (2023-03-01)

Long‐term disease course of two patients with multiple sulfatase deficiency differs from metachromatic leukodystrophy in a broad cohort
by: Stefanie Beck‐Wödl, et al.
Published: (2021-03-01)

Acetobacter indonesiensis Bacteremia in Child with Metachromatic Leukodystrophy
by: Rebekka Kohlmann, et al.
Published: (2016-09-01)

Identification of a novel mutation in ARSA gene in three patients of an Iranian family with metachromatic leukodystrophy disorder
by: Neda Golchin, et al.
Published: (2017-11-01)

MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation
by: Joana Feldmann, et al.
Published: (2023-01-01)

Lipidomic analysis identifies age-disease-related changes and potential new biomarkers in brain-derived extracellular vesicles from metachromatic leukodystrophy mice
by: Melissa R. Pergande, et al.
Published: (2022-03-01)

A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel
by: Nigel Armstrong, et al.
Published: (2023-08-01)

Measurement of sulfatides in the amniotic fluid supernatant: A useful tool in the prenatal diagnosis of metachromatic leukodystrophy
by: Francyne Kubaski, et al.
Published: (2022-03-01)

The Leukodystrophy Spectrum in Saudi Arabia: Epidemiological, Clinical, Radiological, and Genetic Data
by: Majid Alfadhel, et al.
Published: (2021-05-01)

Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix
by: Marena Trinidad, et al.
Published: (2023-07-01)

Inventory of current practices regarding hematopoietic stem cell transplantation in metachromatic leukodystrophy in Europe and neighboring countries
by: Daphne H. Schoenmakers, et al.
Published: (2024-02-01)